Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT01213004
Eligibility Criteria:
Inclusion Criteria:
* Patients must have histologic proof of a thoracic or abdominal malignancy, confirmed at MSKCC and suitable for radiation therapy, in order to be eligible for this study. Thoracic malignancies (study group 1) include those in lung and gastro-esophageal junction. Abdominal malignancies (study group 2) include those in liver and pancreas. Patients having both thoracic and abdominal malignancies will be placed in only one of the study groups, because the limited field-of-view of the CBCT precludes imaging of both malignancies in the same scan. Patients must be older than 18 years of age
* At least part of the tumor must be visible as observed in a diagnostic or planning CT. The tumor must exhibit at least 5 mm motion from respiration as observed in the respiration-correlated CT (RCCT) at simulation. The RCCT scan must be interpretable and not exhibit excessive motion artifacts caused by irregular patient breathing.
* Patients must have Karnofsky Performance Status ≥ 70%
Exclusion Criteria:
* Mesothelioma and other tumors of the pleura
* Pregnant Women
* Allergic to iodine or intravenous contrast agent (applies only to patients with a pancreas or liver malignancy)
* Renal impairment due to the use of a contrast agent
* Patients with pacemakers and defibrillators
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01213004
Study Brief:
Protocol Section:
NCT01213004